Literature DB >> 4291000

Antibodies to synthetic corticotrophin.

J P Felber, S H Ashcroft, A Villanueva, A Vannotti.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 4291000     DOI： 10.1038/211654a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Development of antibodies during long-term therapy with corticotrophin in rheumatoid arthritis. II. Zinc tetracosactrin (Depot Synacthen).

Authors:  D Glass; G Nuki; J R Daly
Journal:  Ann Rheum Dis       Date:  1971-11       Impact factor: 19.103

2.  Comparison of depot tetracosactrin and corticotrophin gel.

Authors:  B L Treadwell; P M Dennis
Journal:  Br Med J       Date:  1969-12-20

3.  Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.

Authors:  D Glass; L Roffe; R N Maini; D G Wraith; G Nuki
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

4.  Acquired Resistance to Corticotropin Therapy in Nephrotic Syndrome: Role of De Novo Neutralizing Antibody.

Authors:  Pei Wang; Yan Zhang; Yu Wang; Andrew S Brem; Zhangsuo Liu; Rujun Gong
Journal:  Pediatrics       Date:  2017-07       Impact factor: 7.124

5.  Spontaneous and tetracosactide-induced anti-ACTH antibodies in man.

Authors:  Earn H Gan; Katie MacArthur; Anna L Mitchell; Abhijit Joshi; Patricia Crock; Simon H S Pearce
Journal:  Clin Endocrinol (Oxf)       Date:  2015-06-25       Impact factor: 3.478
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.